Showing 1 - 12 results of 12 for search 'E. M Slonimskaya', query time: 0.03s Refine Results
  1. 1
    IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER

    IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER by E. M. Slonimskaya, N. A. Tarabanovskaya, A. V. Doroshenko, S. V. Patalyak

    Published 2016-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The influence of functional skewness on prognosis of cancer of mammary gland

    The influence of functional skewness on prognosis of cancer of mammary gland by L. E. Erendeeva, M. V. Zavyalova, E. M. Slonimskaya, V. M. Perelmuter

    Published 2002-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer

    Association between the molecular markers, effect and time of response to the androgen-deprivation therapy in patients with prostate cancer by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. A. Usynin, E. M. Slonimskaya

    Published 2019-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION

    TRANSCRIPTION FACTOR BRN-3α AND PROSTATE CANCER, RELATION WITH HORMONE RECEPTORS AND AKT/M-TOR SIGNALING PATHWAY ACTIVATION by L. V. Spirina, A. K. Gorbunov, I. V. Kondakova, E. M. Slonimskaya, E. A. Usynin

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    EXPRESSION OF TRANSCRIPTION FACTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR AND ACTIVITY OF INTRACELLULAR PROTEASES IN LOCALIZED AND DISSEMINATED KIDNEY CANCERS

    EXPRESSION OF TRANSCRIPTION FACTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR AND ACTIVITY OF INTRACELLULAR PROTEASES IN LOCALIZED AND DISSEMINATED KIDNEY CANCERS by L. V. Spirina, Ye. A. Usynin, I. V. Kondakova, Z. A. Yurmazov, E. M. Slonimskaya

    Published 2016-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    IMPACT OF TRANSCRIPTION FACTORS, VEGF AND PROTEASES ON KIDNEY CANCER PROGRESSION

    IMPACT OF TRANSCRIPTION FACTORS, VEGF AND PROTEASES ON KIDNEY CANCER PROGRESSION by L. V. Spirina, I. V. Kondakova, E. A. Usynin, E. M. Slonimskaya, Z. A. Yurmazov

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients

    The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients by N. N. Babyshkina, T. A. Dronova, E. A. Zambalova, M. V. Zavyalova, E. M. Slonimskaya, N. V. Cherdyntseva

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER

    HETEROGENENOUS EXPRESSION OF MARKERS ASSOCIATED WITN INVASIVE BREAST CANCER by N. V. Krakhmal, M. V. Zavyalova, V. M. Perelmuter, S. V. Vtorushin, E. M. Slonimskaya, E. V. Denisov

    Published 2016-10-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    THE ROLE OF GROWTH AND TRANSCRIPTION FACTORS IN EVALUATING THE EFFECTIVENESS OF NEOADYUVANTNOY CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER

    THE ROLE OF GROWTH AND TRANSCRIPTION FACTORS IN EVALUATING THE EFFECTIVENESS OF NEOADYUVANTNOY CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER by E. A. Usynin, L. V. Spirinа, E. M Slonimskaya, I. V. Kondakova, E. G. Grigoriev, A. K. Gorbunov

    Published 2016-12-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS

    RELATIONSHIP OF THE IMMUNOLOGICAL PARAMETRES WITH NEOADJUVANT CHEMOTHERAPY EFFECTIVENESS IN BREAST CANCER PATIENTS by Y. V. Kukharev, M. N. Stakheeva, A. V. Doroshenko, N. V. Litvyakov, N. N. Babyshkina, E. M. Slonimskaya, N. V. Cherdyntseva

    Published 2016-02-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Monocytes and cancer: promising role as a diagnostic marker and application in therapy

    Monocytes and cancer: promising role as a diagnostic marker and application in therapy by M. R. Patysheva, M. N. Stakheeva, I. V. Larionova, N. A. Tarabanovskaya, E. S. Grigorieva, E. M. Slonimskaya, J. G. Kzhyshkowska, N. V. Cherdyntseva

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION

    EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION by N. V. Litviakov, M. M. Tsyganov, M. K. Ibragimova, I. V. Deryusheva, P. V. Kazantseva, I. V. Mitrofanova, I. G. Frolova, M. A. Buldakov, E. M. Slonimskaya, E. L. Choinzonov, Yu. G. Kzhyshkovska, N. V. Cherdyntseva

    Published 2017-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: